Dallas, Texas 08/20/2014 (FINANCIALSTRENDS) – Waters Corporation (NYSE:WAT) which is based out of Milford, US is a manufacturer, involved in sale and services of analytical instruments for scientific instruments.
In the past few quarters, this instrumentation developer and manufacturer has been strengthening its repertoire in recent times. It includes the Rapid Evaporative Ionization Mass Spectrometry or REIMS from MediMass Ltd.
This platform is disruptive in many ways and empowers WAT with the wide array of patent applications, database as well as software, besides expertise in REIMS.
As Vice President Rohit Khanna, of worldwide Marketing and Informatics, Waters Division noted, Reims technology works to strengthen Health Sciences. He shared that along with Prosolia Inc, which it recently acquired for its Desorption Electrospray Ionization (DESI) technology for clinical applications.
Waters Corporation (NYSE:WAT) which indicated direct-from-sample ion source technologies for strategic discrimination. The idea, according to WAT is to grow mass spectrometery through the process called as Health Sciences Continuum.
Waters Corporation (NYSE:WAT) take on REIMS is its enabling technology, ‘Intelligent Knife’ or iKnife which is in the conceptual stages of development and are ideal for use in surgery on a real-time basis. The company has commented that it is exploring the viability of the application in line with other applicable regulatory needs. However, thus far, there have been no regulatory approvals sought for the device.
The company reiterates its faith in the REIMS technology, as the platform is based on ionization technique. The company claims that it can be used as a source for direct analysis of various samples through the method of mass spectrometry.
REIMs claims that its ability to bring ionization to sampling in the range of real world applications for food safety as well as microbiology is indeed a winner!